• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种花青素与益生元混合物对肥胖男性和女性受试者肠道环境的功效

Efficacy of an Anthocyanin and Prebiotic Blend on Intestinal Environment in Obese Male and Female Subjects.

作者信息

Hester Shelly N, Mastaloudis Angela, Gray Russell, Antony Joseph M, Evans Mal, Wood Steven M

机构信息

Pharmanex Research, NSE Products Inc., 75 West Center Street, Provo, UT 84601, USA.

KGK Science Inc., 255 Queens Avenue, Suite 1440, London, Ontario, Canada N6A 5R8.

出版信息

J Nutr Metab. 2018 Sep 13;2018:7497260. doi: 10.1155/2018/7497260. eCollection 2018.

DOI:10.1155/2018/7497260
PMID:30302287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6158948/
Abstract

BACKGROUND

Anthocyanins and prebiotics impact overall health and wellness, likely through modulation of the microbiota and the intestinal ecosystem.

OBJECTIVES

An 8-week open-label study in male and female volunteers with uncomplicated obesity was designed to study the efficacy of an anthocyanin and prebiotic blend in modulating intestinal microbiota and intestinal inflammation.

RESULTS

After 8 weeks of daily supplementation, participants had a significant decrease in Firmicutes ( < 0.001) and Actinobacteria ( < 0.001) and a significant increase in Bacteroidetes ( < 0.001). Bowel habits were improved as evidenced by reductions in the severity of bloating ( < 0.05), gas (=0.035), and abdominal pain (=0.015) as well as significant improvements in stool consistency ( < 0.05). Finally, a nonsignificant decrease in the inflammatory marker fecal calprotectin was seen (=0.107). The supplement was safe and well tolerated.

CONCLUSIONS

The results suggest that regular consumption of the anthocyanin-prebiotic blend positively modulated the intestinal ecosystem and provided insights into the mechanisms of action and its impact on health benefits.

摘要

背景

花青素和益生元可能通过调节微生物群和肠道生态系统来影响整体健康。

目的

设计一项针对无并发症肥胖男性和女性志愿者的为期8周的开放标签研究,以研究花青素和益生元混合物在调节肠道微生物群和肠道炎症方面的功效。

结果

每日补充8周后,参与者的厚壁菌门(<0.001)和放线菌门(<0.001)显著减少,拟杆菌门显著增加(<0.001)。腹胀严重程度(<0.05)、气体(=0.035)和腹痛(=0.015)减轻,粪便稠度显著改善(<0.05),证明肠道习惯得到改善。最后,炎症标志物粪便钙卫蛋白出现非显著下降(=0.107)。该补充剂安全且耐受性良好。

结论

结果表明,定期食用花青素-益生元混合物可对肠道生态系统产生积极调节作用,并为其作用机制及其对健康益处的影响提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74b/6158948/11d6d8179634/JNME2018-7497260.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74b/6158948/431aea406c56/JNME2018-7497260.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74b/6158948/d6e4be19429b/JNME2018-7497260.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74b/6158948/afcba9065fc7/JNME2018-7497260.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74b/6158948/c4bf046c9f6c/JNME2018-7497260.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74b/6158948/11d6d8179634/JNME2018-7497260.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74b/6158948/431aea406c56/JNME2018-7497260.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74b/6158948/d6e4be19429b/JNME2018-7497260.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74b/6158948/afcba9065fc7/JNME2018-7497260.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74b/6158948/c4bf046c9f6c/JNME2018-7497260.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74b/6158948/11d6d8179634/JNME2018-7497260.005.jpg

相似文献

1
Efficacy of an Anthocyanin and Prebiotic Blend on Intestinal Environment in Obese Male and Female Subjects.一种花青素与益生元混合物对肥胖男性和女性受试者肠道环境的功效
J Nutr Metab. 2018 Sep 13;2018:7497260. doi: 10.1155/2018/7497260. eCollection 2018.
2
Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.益生菌 UG1601 可减轻与肠道菌群相关的便秘相关事件:一项随机安慰剂对照干预研究。
World J Gastroenterol. 2019 Oct 28;25(40):6129-6144. doi: 10.3748/wjg.v25.i40.6129.
3
Prebiotic effects: metabolic and health benefits.益生元作用:代谢与健康益处。
Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363.
4
Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.粪便微生物群移植可减轻部分以腹胀为主的肠易激综合征患者的症状:一项安慰剂对照随机试验的短期和长期结果
Gastroenterology. 2021 Jan;160(1):145-157.e8. doi: 10.1053/j.gastro.2020.07.013. Epub 2020 Jul 15.
5
Effect of a prebiotic galactooligosaccharide mixture (B-GOS®) on gastrointestinal symptoms in adults selected from a general population who suffer with bloating, abdominal pain, or flatulence.双歧杆菌来源的低聚半乳糖混合物(B-GOS®)对一般人群中腹胀、腹痛或肠胃气胀的成年人胃肠道症状的影响。
Neurogastroenterol Motil. 2018 Nov;30(11):e13440. doi: 10.1111/nmo.13440. Epub 2018 Aug 15.
6
Resolution of acute gastroenteritis symptoms in children and adults treated with a novel polyphenol-based prebiotic.用一种新型基于多酚的益生元治疗的儿童和成人急性肠胃炎症状的缓解情况
World J Gastroenterol. 2014 Sep 14;20(34):12301-7. doi: 10.3748/wjg.v20.i34.12301.
7
Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients.术前补充益生元对结直肠癌患者免疫指标及肠道菌群结构的影响。
Nutrition. 2019 May;61:132-142. doi: 10.1016/j.nut.2018.10.038. Epub 2018 Nov 29.
8
A Novel Prebiotic Blend Product Prevents Irritable Bowel Syndrome in Mice by Improving Gut Microbiota and Modulating Immune Response.一种新型的益生元混合物产品通过改善肠道微生物群和调节免疫反应来预防小鼠的肠易激综合征。
Nutrients. 2017 Dec 9;9(12):1341. doi: 10.3390/nu9121341.
9
Microbiota benefits after inulin and partially hydrolized guar gum supplementation: a randomized clinical trial in constipated women.补充菊粉和部分水解瓜尔胶后微生物群的益处:一项针对便秘女性的随机临床试验
Nutr Hosp. 2012 Jan-Feb;27(1):123-9. doi: 10.1590/S0212-16112012000100014.
10
In vitro gastrointestinal digestion and fecal fermentation reveal the effect of different encapsulation materials on the release, degradation and modulation of gut microbiota of blueberry anthocyanin extract.体外胃肠道消化和粪便发酵揭示了不同包埋材料对蓝莓花色苷提取物释放、降解和肠道微生物群调节的影响。
Food Res Int. 2020 Jun;132:109098. doi: 10.1016/j.foodres.2020.109098. Epub 2020 Feb 19.

引用本文的文献

1
Reinventing gut health: leveraging dietary bioactive compounds for the prevention and treatment of diseases.重塑肠道健康:利用膳食生物活性化合物预防和治疗疾病。
Front Nutr. 2024 Oct 22;11:1491821. doi: 10.3389/fnut.2024.1491821. eCollection 2024.
2
Anthocyanins: Metabolic Digestion, Bioavailability, Therapeutic Effects, Current Pharmaceutical/Industrial Use, and Innovation Potential.花青素:代谢消化、生物利用度、治疗效果、当前制药/工业用途及创新潜力
Antioxidants (Basel). 2022 Dec 26;12(1):48. doi: 10.3390/antiox12010048.
3
The Impact of Dietary Fiber as a Prebiotic on Inflammation in Children with Obesity.

本文引用的文献

1
Cyanidin and delphinidin modulate inflammation and altered redox signaling improving insulin resistance in high fat-fed mice.矢车菊素和飞燕草素通过调节炎症和氧化还原信号改善高脂肪喂养小鼠的胰岛素抵抗。
Redox Biol. 2018 Sep;18:16-24. doi: 10.1016/j.redox.2018.05.012. Epub 2018 May 30.
2
Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population.乌克兰成年人群体中体重指数与厚壁菌门/拟杆菌门比例之间的关联。
BMC Microbiol. 2017 May 22;17(1):120. doi: 10.1186/s12866-017-1027-1.
3
Contribution of anthocyanin-rich foods in obesity control through gut microbiota interactions.
膳食纤维作为益生元对肥胖儿童炎症的影响
Foods. 2022 Sep 15;11(18):2856. doi: 10.3390/foods11182856.
4
Phytonutrients: Sources, bioavailability, interaction with gut microbiota, and their impacts on human health.植物营养素:来源、生物利用度、与肠道微生物群的相互作用及其对人类健康的影响。
Front Nutr. 2022 Aug 16;9:960309. doi: 10.3389/fnut.2022.960309. eCollection 2022.
5
The Impact of Plant Phytochemicals on the Gut Microbiota of Humans for a Balanced Life.植物化学物质对人类肠道微生物群的影响,以实现平衡的生活。
Int J Mol Sci. 2022 Jul 23;23(15):8124. doi: 10.3390/ijms23158124.
6
Chemical Compounds of Berry-Derived Polyphenols and Their Effects on Gut Microbiota, Inflammation, and Cancer.浆果来源的多酚化合物及其对肠道微生物群、炎症和癌症的影响的化学组成。
Molecules. 2022 May 20;27(10):3286. doi: 10.3390/molecules27103286.
7
Polyphenols-Gut Microbiota Interrelationship: A Transition to a New Generation of Prebiotics.多酚-肠道微生物群相互关系:向新一代益生元的转变。
Nutrients. 2021 Dec 28;14(1):137. doi: 10.3390/nu14010137.
8
Polyphenols as modulators of pre-established gut microbiota dysbiosis: State-of-the-art.多酚作为预先存在的肠道微生物失调的调节剂:最新进展。
Biofactors. 2022 Mar;48(2):255-273. doi: 10.1002/biof.1772. Epub 2021 Aug 16.
9
Uniaxial and Coaxial Electrospinning for Tailoring Jussara Pulp Nanofibers.单轴和同轴静电纺丝用于定制贾萨拉果肉纳米纤维。
Molecules. 2021 Feb 24;26(5):1206. doi: 10.3390/molecules26051206.
10
Harnessing machine learning for development of microbiome therapeutics.利用机器学习开发微生物组治疗方法。
Gut Microbes. 2021 Jan-Dec;13(1):1-20. doi: 10.1080/19490976.2021.1872323.
富含花色苷的食物通过与肠道微生物群相互作用在肥胖控制中的作用。
Biofactors. 2017 Jul 8;43(4):507-516. doi: 10.1002/biof.1365. Epub 2017 May 15.
4
Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial.益生菌加或不加膳食纤维可控制超重和肥胖成年人的体脂量,与血清连蛋白有关——随机对照试验
EBioMedicine. 2016 Nov;13:190-200. doi: 10.1016/j.ebiom.2016.10.036. Epub 2016 Oct 26.
5
Faecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn's Disease.粪便钙卫蛋白:影响其水平的因素及其作为克罗恩病发病风险替代标志物的潜在作用。
BMC Gastroenterol. 2016 Oct 7;16(1):126. doi: 10.1186/s12876-016-0535-z.
6
The healthy human microbiome.健康的人类微生物组。
Genome Med. 2016 Apr 27;8(1):51. doi: 10.1186/s13073-016-0307-y.
7
Recent Progress in Anti-Obesity and Anti-Diabetes Effect of Berries.浆果在抗肥胖和抗糖尿病方面的最新进展。
Antioxidants (Basel). 2016 Apr 6;5(2):13. doi: 10.3390/antiox5020013.
8
Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders.益生菌与益生元:代谢紊乱的现状与未来展望
Nutrients. 2016 Mar 18;8(3):173. doi: 10.3390/nu8030173.
9
New insights into the bioavailability of red raspberry anthocyanins and ellagitannins.红树莓花色苷和鞣花单宁生物利用度的新见解。
Free Radic Biol Med. 2015 Dec;89:758-69. doi: 10.1016/j.freeradbiomed.2015.10.400. Epub 2015 Oct 22.
10
Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk.高脂饮食对肠道微生物群的影响:慢性疾病风险的驱动因素。
Curr Opin Clin Nutr Metab Care. 2015 Sep;18(5):515-20. doi: 10.1097/MCO.0000000000000209.